SNOT-22 score also improved with dupilumab versus placebo in patients who did not complete the SAT, but the difference did not reach statistical significance.
← all excerpts
Data Mining of Free-Text Responses: An Innovative Approach to Analyzing Patient Perspectives on Treatment for Chronic Rhinosinusitis with Nasal Polyps in a Phase IIa Proof-of-Concept Study for Dupilumab.
1
—
—